A phase I/II study of LDE225, a smoothened (Smo) antagonist, in pediatric patients with recurrent medulloblastoma (MB) or other solid tumors

Autoria(s): Geoerger, Birgit; Aerts, Isabelle; Casanova, Michela; Chisholm, Julia C.; Hargrave, Darren R.; Leary, Sarah; Ashley, David M.; Bouffet, Eric; Macdonald, Tobey; Hurh, Eunju; Dey, Jyotirmoy; Kalambakas, Stacey; Amakye, Dereck Dokyi; Kieran, Mark W.
Contribuinte(s)

[Unknown]
Data(s)

01/01/2012
Identificador

http://hdl.handle.net/10536/DRO/DU:30055016
Idioma(s)

eng
Publicador

American Society of Clinical Oncology
Relação

http://dro.deakin.edu.au/eserv/DU:30055016/ashley-phasestudysmoothenedantagonist-2012.pdf
Direitos

2012, American Society of Clinical Oncology
Palavras-Chave #children #cancer #recurrent medulloblastoma #oncology #LDE225
Tipo

Conference Paper
Acesso ao item digital